According to Alan Balch, PhD, CEO of the Patient Advocate Foundation, having a common language that is centered on the patient is crucial when stakeholders come together with various value frameworks. Ultimately, he said it’s these value frameworks that are going to steer the patients in one way or another.
According to Alan Balch, PhD, CEO of the Patient Advocate Foundation, having a common language that is centered on the patient is crucial when stakeholders come together with various value frameworks. Ultimately, he said it’s these value frameworks that are going to steer the patients in one way or another.
Transcript (slightly modified)
There are a number of different value assessment frameworks that have been created (NCCN, ASCO, ICER). Is there a way to reconcile these different frameworks?
Having some common language around cost, benefits, values, efficacy, safety, etc., because again, patients often think about those things in different terms than other stakeholders. So that’s sort of step 1, is how to come up with some common language and I think that starts with bringing everybody to the table as these things are developed from square one, not at the end of it. Or just in comments, but actually having all of the stakeholders from the healthcare system at the table as those things are being discussed and developed and designed because then you come up with something that does resonate at least with the stakeholders writ large.
But I think at the center of that conversation really should be the patients because that’s ultimately the person or persons to whom the value of the care experience is supposed to accrue. So, if you’re not designing these tools, these value frameworks in the shared decision-making tools in a patient centric way, in a way that patients can understand and interact with in a meaningful way and that delivers outcomes of information that are really personal to the patient, than it’s not going to be as effective as a tool to the individual patient.
It may benefit other stakeholders in the system, but I think the ultimate goal should be in a way to reconcile some of the differences between them as to have them be multi-collaborative stakeholder initiatives from the beginning with a strong emphasis on patient centeredness and having the patient voice—not just a patient or a couple of patients, but patient representatives as well as patient organizations at the table contributing to the development of the different inputs that are going to be a part of that tool, the cost variables, the benefit variables. What is value? Ultimately, what is the decision point upon which that value framework is going to be steering a patient one way or the other.
Dr Kathryn Lindley Explains the Importance of Cardio-Obstetrics in Fellowship Programs
December 5th 2023Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, talks about why it’s important to incorporate cardio-obstetrics training into cardiovascular disease fellowship programs.
Read More
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Christine Pfaff on Ensuring Patient Access to Affordable Treatments
October 17th 2023To ensure patients are getting timely access to their treatments, there needs to be better collaboration between payers and providers, said Christine Pfaff, RPh, senior regional director of operations, American Oncology Network.
Read More